Charles River Laboratories International (CRL) Amortization of Deferred Charges (2010 - 2016)

Charles River Laboratories International has reported Amortization of Deferred Charges for 7 years, with the latest figure at $506000.0 in Q4 2016.

• On a quarterly basis, Amortization of Deferred Charges rose 23.41% year-over-year to $506000.0 in Q4 2016; TTM through Dec 2016 was $2.8 million, a 18.95% increase from a year earlier, with the FY2016 full-year figure at $2.8 million, up 18.95% from the prior year.
• Amortization of Deferred Charges was $506000.0 for Q4 2016 at Charles River Laboratories International, up from $34000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $4.6 million in Q1 2013, with the low at $34000.0 in Q3 2016.
• Average Amortization of Deferred Charges over 5 years is $1.7 million, with a median of $436000.0 recorded in 2013.
• The sharpest annual moves came in 2015 and 2016: Amortization of Deferred Charges soared 165.36% in 2015, then plunged 91.46% in 2016.
• Over 5 years, Amortization of Deferred Charges stood at $4.5 million in 2012, then sank by 90.26% to $437000.0 in 2013, then decreased by 2.29% to $427000.0 in 2014, then slipped by 3.98% to $410000.0 in 2015, then rose by 23.41% to $506000.0 in 2016.
• The last three Amortization of Deferred Charges figures came in at $506000.0 (Q4 2016), $34000.0 (Q3 2016), and $1.9 million (Q2 2016), per Business Quant data.